Skip to main content
SpringerLink
Log in

Ablation of Catecholaminergic Polymorphic Ventricular Tachycardia

  • Chapter
  • First Online:
Catheter Ablation

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a lethal arrhythmogenic disease characterized by syncope or sudden cardiac death induced by exercise or emotional stress in individuals without organic heart disease. The cause of CPVT is reported to be a gene mutation in RYR2 or CASQ2, and its prognosis is considered to be poor. Various types of adrenergic-induced arrhythmias, including not only ventricular but also supraventricular arrhythmias, are accompanied by and result in syncope or sudden cardiac death. Notably, bidirectional ventricular tachycardia is unique to this disease. The therapeutic management of CPVT primarily includes exercise restriction, beta-blockers, and implantable cardioverter defibrillator implantation, and the main purpose of therapy is to prevent sudden cardiac death caused by fatal arrhythmia. Catheter ablation is regarded as one of the most effective therapies for CPVT patients with drug refractory arrhythmias. Some case reports describing successful ablation of ventricular arrhythmias or atrial tachycardia/atrial fibrillation have been published; however, the data remains limited as no large cohort studies have been performed and the long-term success rate is unclear. Further investigation is required to elucidate the feasibility of ablation for ventricular and supraventricular arrhythmias.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512–9.

    Article  CAS  PubMed  Google Scholar 

  2. Sumitomo N. Current topics in catecholaminergic polymorphic ventricular tachycardia. J Arrhythm. 2016;32:344–51.

    Article  PubMed  Google Scholar 

  3. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200.

    Article  CAS  PubMed  Google Scholar 

  4. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, Lorber A, Kastner DL, Goldman B, Pras E. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13–21. Circulation. 2001;103:2822–7.

    Article  CAS  PubMed  Google Scholar 

  5. Sumitomo N, Sakurada H, Taniguchi K, Matsumura M, Abe O, Miyashita M, Kanamaru H, Karasawa K, Ayusawa M, Fukamizu S, Nagaoka I, Horie M, Harada K, Hiraoka M. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J. 2007;71:1606–9.

    Article  PubMed  Google Scholar 

  6. Baher AA, Uy M, Xie F, Garfinkel A, Qu Z, Weiss JN. Bidirectional ventricular tachycardia: ping pong in the His-Purkinje system. Heart Rhythm. 2011;8:599–605.

    Article  PubMed  Google Scholar 

  7. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932–63.

    Article  PubMed  Google Scholar 

  8. Swan H, Laitinen P, Kontula K, Toivonen L. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol. 2005;16:162–6.

    Article  PubMed  Google Scholar 

  9. Rosso R, Kalman JM, Rogowski O, Diamant S, Birger A, Biner S, Belhassen B, Viskin S. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4:1149–54.

    Article  PubMed  Google Scholar 

  10. Watanabe H, van der Werf C, Roses-Noguer F, Adler A, Sumitomo N, Veltmann C, Rosso R, Bhuiyan ZA, Bikker H, Kannankeril PJ, Horie M, Minamino T, Viskin S, Knollmann BC, Till J, Wilde AA. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2013;10:542–7.

    Article  PubMed  Google Scholar 

  11. De Ferrari GM, Dusi V, Spazzolini C, Bos JM, Abrams DJ, Berul CI, Crotti L, Davis AM, Eldar M, Kharlap M, Khoury A, Krahn AD, Leenhardt A, Moir CR, Odero A, Olde Nordkamp L, Paul T, Roses I Noguer F, Shkolnikova M, Till J, Wilde AA, Ackerman MJ, Schwartz PJ. Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015;131:2185–93.

    Article  PubMed  Google Scholar 

  12. Mohamed U, Gollob MH, Gow RM, Krahn AD. Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia. Heart Rhythm. 2006;3:1486–9.

    Article  PubMed  Google Scholar 

  13. Kaneshiro T, Naruse Y, Nogami A, Tada H, Yoshida K, Sekiguchi Y, Murakoshi N, Kato Y, Horigome H, Kawamura M, Horie M, Aonuma K. Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation. Circ Arrhythm Electrophysiol. 2012;5:e14–7.

    Article  PubMed  Google Scholar 

  14. Sumitomo N, Nakamura T, Fukuhara J, Nakai T, Watanabe I, Mugishima H, Hiraoka M. Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia. Heart Vessel. 2010;25:448–52.

    Article  Google Scholar 

  15. Sugiyasu A, Oginosawa Y, Nogami A, Hata Y. A case with catecholaminergic polymorphic ventricular tachycardia unmasked after successful ablation of atrial tachycardias from pulmonary veins. Pacing Clin Electrophysiol. 2009;32:e21–4.

    Article  PubMed  Google Scholar 

  16. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pizzale S, Gollob MH, Gow R, Birnie DH. Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:1319–21.

    Article  PubMed  Google Scholar 

  18. Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T, Ferrandi C, Koolbergen DR, Odero A, Schwartz PJ. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024–9.

    Article  CAS  PubMed  Google Scholar 

  19. Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, Danilo P, Ravens U, Rosen MR, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 2005;111:2025–32.

    Article  CAS  PubMed  Google Scholar 

  20. Wongcharoen W, Chen YC, Chen YJ, Chen SY, Yeh HI, Lin CI, Chen SA. Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents. Heart Rhythm. 2007;4:1338–49.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan

    Keita Masuda, Takashi Kaneshiro & Kazutaka Aonuma

Authors
  1. Keita Masuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Kaneshiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazutaka Aonuma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazutaka Aonuma .

Editor information

Editors and Affiliations

  1. Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan

    Kenzo Hirao

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Masuda, K., Kaneshiro, T., Aonuma, K. (2018). Ablation of Catecholaminergic Polymorphic Ventricular Tachycardia. In: Hirao, K. (eds) Catheter Ablation. Springer, Singapore. https://doi.org/10.1007/978-981-10-4463-2_38

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4463-2_38

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4462-5

  • Online ISBN: 978-981-10-4463-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation